Intellectual Property India Publishes Patent Application for 'Inhibitors Of Cyclin-Dependent Kinase (CDK) 12 And/Or CDK13 And Uses Thereof' Filed by Insilico Medicine Ip Limited

MUMBAI, India, March 7 -- Intellectual Property India has published a patent application (202517012355 A) filed by Insilico Medicine Ip Limited, Hong Kong, on Feb. 13, for 'inhibitors of cyclin-dependent kinase (cdk) 12 and/or cdk13 and uses thereof.'

Inventor(s) include Lu, Hongfu; Liu, Yingtao; Wu, Jianping; Zheng, Min; and Ren, Feng.

The application for the patent was published on March 7, under issue no. 10/2025.

According to the abstract released by the Intellectual Property India: "Described herein are inhibitors of cyclin-dependent kinase (CDK) 12 and/or CDK13 (and pharmaceutical compositions comprising the inhibitors. The subject compounds and compositions are useful for the treatment of a disease or disorder associated with over...